DOI:
10.1055/s-00000160
neuroreha
LinksClose Window
References
Montalban X, Hauser SL, Kappos L. et al.
Ocrelizumab versus placebo in primary progressive multiple sclerosis.
N Engl J Med 2017;
376: 209-220
We do not assume any responsibility for the contents of the web pages of other providers.